FilingIndex
DEF 14AThe Ballot

Theriva Biologics, Inc. files DEF 14A

Filed Jul 9, 2025 · 11mo ago · Accession 0001104659-25-066731

Plain English

Proxy statement — executive pay, board nominees, and shareholder votes.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
TOVX
CIK
894158
Form type
DEF 14A
Filing date
Jul 9, 2025
Report date
Aug 29, 2025
Document
tm2520034-2_def14a.htm
Size
2.8 MB